000 01519 a2200409 4500
005 20250512195824.0
264 0 _c19830214
008 198302s 0 0 eng d
022 _a0024-3205
024 7 _a10.1016/0024-3205(82)90540-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSnider, R M
245 0 0 _aNoradrenergic-mediated potentiation of acetylcholine release from the phrenic nerve: evidence for presynaptic alpha 1-adrenoceptor involvement.
_h[electronic resource]
260 _bLife sciences
_cAug 1982
300 _a853-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcetylcholine
_xmetabolism
650 0 4 _aAdrenergic alpha-Antagonists
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aClonidine
_xpharmacology
650 0 4 _aDioxanes
_xpharmacology
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMuscle Contraction
_xdrug effects
650 0 4 _aNorepinephrine
_xpharmacology
650 0 4 _aPhentolamine
_xpharmacology
650 0 4 _aPhenylephrine
_xpharmacology
650 0 4 _aPhrenic Nerve
_xdrug effects
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Adrenergic
_xphysiology
650 0 4 _aReceptors, Adrenergic, alpha
_xdrug effects
650 0 4 _aYohimbine
_xpharmacology
700 1 _aGerald, M C
773 0 _tLife sciences
_gvol. 31
_gno. 9
_gp. 853-7
856 4 0 _uhttps://doi.org/10.1016/0024-3205(82)90540-9
_zAvailable from publisher's website
999 _c6129643
_d6129643